- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03991182
Evaluation of Scaling Up Early Childhood Development in Zambia (SUpErCDZ)
In Zambia, 40% of children under five years of age are stunted and 6% are wasted. While the Zambian government has focused on child nutrition in recent years, more focus on holistically improving early child development (ECD) is needed. Through a previous randomized controlled trial, the investigators developed a community-based parenting intervention and demonstrated that this intervention can improve children's developmental outcomes in Zambia, including nutritional status and their early language development. During fortnightly group meetings, parents learn a diverse curriculum that includes content on: 1) cognitive stimulation and play practices; 2) child nutrition and cooking practices; and 3) self-care for good mental health. This information and learning content is delivered by supervised community volunteers using an interactive theatre-based approach.
In this study, the newly established maternity waiting homes (MWHs) and affiliated Safe Motherhood Action Group leaders (SMAGs) will be used as a novel platform to launch and support community-based parenting groups, embedding this program directly into the existing health system, and making them more feasible for scale-up and sustainability.
Despite the positive impact of the proposed parenting-group model in the pilot trial, this model is not currently operating in Zambia. By integrating this intervention into the existing health system, large populations of rural children exposed to high levels of adversity in the critical early years of life could be reached in a nationally scalable fashion. As part of this project, the investigators propose to implement and rigorously assess the impact of this approach in four districts of Zambia.
Study Overview
Status
Conditions
Detailed Description
This research will utilize a cluster-randomized controlled trial with integrated mixed-methods process evaluation to understand the impact of parenting groups on child development outcomes when delivered at scale. The specific objectives are to: 1) assess the impact of the intervention on early childhood development outcomes; 2) assess the degree to which the intervention was implemented according to the project plan and to document adjustments made during the course of the project; 3) describe and document the perceptions of caregivers on parent groups, as well as any behavioral changes in parenting or in mother support networks resulting from participating in parenting groups; and approaches to achieving caregiving gender equality at household level; and, 4) generate a set of recommendations for the Government of the Republic of Zambia to further adapt and/or scale up community parenting groups based on the summative findings from this study.
For the impact evaluation the investigators will collect data from two main sources: 1) Household Surveys and 2) In-depth interviews at both baseline and endline data collection. In addition, at endline we will assess child development using the Malawi Developmental Assessment Tool (MDAT).
For the process evaluation, the investigators will conduct record review of parenting groups attendance registers and SMAG log books. The investigators will conduct in-depth interviews with health systems staff (province, district and health facility), SMAGs, and head women from all intervention sites, and focus group discussions with caregivers who meet the study eligibility criteria in both intervention and control zones.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Eastern
-
Nyimba, Eastern, Zambia
- Nyimba District Medical Office
-
-
Southern
-
Choma, Southern, Zambia
- Choma District Medical Office
-
Kalomo, Southern, Zambia
- Kalomo District Medical Office
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Caregiver-child dyads in the impact cohort
Inclusion Criteria:
- Children aged 0-5 months at baseline in the catchment areas of the ten selected health facilities in Southern and Eastern Provinces will be eligible to participate
- Child's primary caregiver must be 15 years or older
- Child's primary caregiver must be a female (because the participants in the women's group may feel uncomfortable discussing certain issues if a man is present)
Exclusion Criteria:
- Caregivers who are unwilling to provide informed consent
- Families that plan to move from their health center catchment zone during the period of the study
In-depth interviews (IDI)
Inclusion Criteria:
- A member of the health facility staff at a study site for at least 6 months; or
- A district or provincial level health staff; or
- A SMAG member at a study site who has been trained to implement the parenting group intervention; or
- A 'head mother' leading parenting group sessions within their communities; and ≥18 years of age and provided informed consent to participate in the IDI.
Exclusion criteria
-None
Focus group discussions (FGDs)
Inclusion Criteria:
- A woman or a man with child under 3 years of age; or
- Community health volunteers [SMAG, community health worker (CHW) or TBA]; and
- Resident within the project zones; and -≥18 years of age
Exclusion Criteria:
-None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Community-based parenting group
The community-based parenting group will include 39 health zones and 585 caregiver-child dyads
|
50 volunteers (primarily SMAGs- Safe Motherhood Action Group members) associated with the health facility will be trained using a training -of-trainers approach on the e ECD (early childhood development) curriculum
Each of the 50 trained SMAGs will train 10 head women on the ECD curriculum
Every two weeks 500 trained head women lead parent group meetings on childhood development and nutrition to caregiver-child dyads
|
Active Comparator: Control group
The control group will include 39 health zones and 585 caregiver-child dyads
|
The traditional care and education of caregivers/parents for children 0-5 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Child linear growth: Stunting
Time Frame: Children aged 0-5 months at baseline (August-September 2019) and end line (September 2021), child aged 24-29 months
|
Heights of all study children will be measured.
Height-for-age z-scores will be calculated using standard World Health Organization (WHO) criteria.
Stunting will be defined as having a height-for-age z-score < -2.
The difference in the prevalence of stunting between children in the intervention and comparison areas will be determined.
|
Children aged 0-5 months at baseline (August-September 2019) and end line (September 2021), child aged 24-29 months
|
Child development z-scores based on Malawi Developmental Assessment Tool (MDAT)
Time Frame: At endline (child aged 24-29 months) children are assessed using the MDAT. Scores are standardized within the study sample for analysis.
|
Cognitive function measurements
|
At endline (child aged 24-29 months) children are assessed using the MDAT. Scores are standardized within the study sample for analysis.
|
Caregiver Reported Early Development Index
Time Frame: Children aged 0-5 months at baseline (August-September 2019) and end line (September 2021), child aged 24-29 months
|
Summary score of child development measures (motor, cognitive, language, and social emotional skills)
|
Children aged 0-5 months at baseline (August-September 2019) and end line (September 2021), child aged 24-29 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of children receiving all age-appropriate vaccines
Time Frame: Baseline (child 0-5 months), Endline (child aged 24-29 months)
|
We will collect data at baseline and endline on whether the study children are up to date on vaccines as recommended by the government vaccination schedule.
|
Baseline (child 0-5 months), Endline (child aged 24-29 months)
|
Proportion of children receiving vitamin A supplementation
Time Frame: Baseline (child 0-5 months), Endline (child aged 24-29 months)
|
Caregivers will be asked about vitamin A supplementation and responses will be compared to child development outcomes
|
Baseline (child 0-5 months), Endline (child aged 24-29 months)
|
Number of well-baby visits attended
Time Frame: Baseline (child 0-5 months), Endline (child aged 24-29 months)
|
Caregivers will be asked about the health seeking behaviors for the child; results will be compared against government recommendations and against child development outcomes
|
Baseline (child 0-5 months), Endline (child aged 24-29 months)
|
Average time spent reading with the child
Time Frame: Baseline (child 0-5 months), Endline (child aged 24-29 months)
|
Caregivers will be asked about their engagement with the child and other adult engagement with the child at baseline and endline
|
Baseline (child 0-5 months), Endline (child aged 24-29 months)
|
Average time spent playing with the child
Time Frame: Baseline (child 0-5 months), Endline (child aged 24-29 months)
|
Caregivers will be asked about their engagement with the child and other adult engagement with the child at baseline and endline
|
Baseline (child 0-5 months), Endline (child aged 24-29 months)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Child diet diversity
Time Frame: Baseline (child 0-5 months), Endline (child aged 24-29 months)
|
Caregivers will be asked about child feeding habits and dietary diversity
|
Baseline (child 0-5 months), Endline (child aged 24-29 months)
|
Caregiver mental health based on the Self Reporting Questionnaire 20-item (SRQ-20)
Time Frame: Baseline (child 0-5 months), Endline (child aged 24-29 months)
|
Caregivers will be asked a series of questions on their personal mental health using an instrument that has been adapted to the context
|
Baseline (child 0-5 months), Endline (child aged 24-29 months)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Nancy A Scott, DrPH MPH, Boston University
- Principal Investigator: Thandiwe Ngoma, Right to Care - Zambia
Publications and helpful links
General Publications
- Rockers PC, Zanolini A, Banda B, Chipili MM, Hughes RC, Hamer DH, Fink G. Two-year impact of community-based health screening and parenting groups on child development in Zambia: Follow-up to a cluster-randomized controlled trial. PLoS Med. 2018 Apr 24;15(4):e1002555. doi: 10.1371/journal.pmed.1002555. eCollection 2018 Apr.
- Rockers PC, Fink G, Zanolini A, Banda B, Biemba G, Sullivan C, Mutembo S, Silavwe V, Hamer DH. Impact of a community-based package of interventions on child development in Zambia: a cluster-randomised controlled trial. BMJ Glob Health. 2016 Nov 22;1(3):e000104. doi: 10.1136/bmjgh-2016-000104. eCollection 2016.
- Scott NA, Kaiser JL, Vian T, Bonawitz R, Fong RM, Ngoma T, Biemba G, Boyd CJ, Lori JR, Hamer DH, Rockers PC. Impact of maternity waiting homes on facility delivery among remote households in Zambia: protocol for a quasiexperimental, mixed-methods study. BMJ Open. 2018 Aug 10;8(8):e022224. doi: 10.1136/bmjopen-2018-022224.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- H-38950
- TTS-1802-21377 (Other Grant/Funding Number: Grand Challenges Canada)
- 72061119FA00001 (Other Grant/Funding Number: United States Agency for International Development (USAID))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Early Childhood Development
-
Stanford UniversityJohns Hopkins University; University of California, Berkeley; International Centre... and other collaboratorsCompletedEarly Childhood DevelopmentBangladesh
-
Duke UniversityCatholic Relief ServicesCompleted
-
University of California, BerkeleyUniversity of Nevada, Reno; World Bank; L'Office National de Nutrition, MadagascarRecruitingEarly Childhood DevelopmentMadagascar
-
Mathematica Policy Research, Inc.The University of Texas Health Science Center, Houston; Department of Health... and other collaboratorsUnknownEarly Childhood Professional DevelopmentUnited States
-
Mathematica Policy Research, Inc.University of Oklahoma; Department of Health and Human Services; Zero to ThreeUnknownEarly Childhood Professional Development
-
The Hospital for Sick ChildrenCompletedEarly Childhood Development | Self ControlCanada
-
The University of Hong KongUnknownEarly Childhood DevelopmentHong Kong
-
Gazi UniversityNot yet recruitingChild Rearing | Growth and Development | Early Childhood Caries
-
International Centre for Diarrhoeal Disease Research...Recruiting
-
Johns Hopkins Bloomberg School of Public HealthCompletedEarly Childhood Development (ECD)
Clinical Trials on SMAGs trained on ECD curriculum
-
Westfälische Wilhelms-Universität MünsterNational Paralympic Committee Germany (NPCG)CompletedCardiac Rehabilitation | Feasibility Studies | Organization and Administration | Rehabilitation ExerciseGermany
-
Universidad Peruana Cayetano HerediaUniversity of WashingtonCompletedHealth Knowledge, Attitudes, Practice | Maternal BehaviorPeru
-
OIHANA SAGASTI ARRIENUniversidad Nacional de Educación a DistanciaActive, not recruitingMental Health Wellness 1Spain
-
Wayne State UniversityNational Institute of Mental Health (NIMH)Completed
-
University of Massachusetts, WorcesterNational Cancer Institute (NCI)CompletedSmoking Cessation | Tobacco Use DisorderUnited States